Literature DB >> 20154232

Functional impairment in chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivity.

M Ruth Lavergne1, Donald C Cole, Kathleen Kerr, Lynn M Marshall.   

Abstract

OBJECTIVE: To characterize patients diagnosed with multiple chemical sensitivity (MCS), chronic fatigue syndrome (CFS), or fibromyalgia (FM), to compare their level of function with Canadian population average values, and to assess factors associated with function.
DESIGN: Chart review and abstraction of clinical information.
SETTING: The Environmental Health Clinic (EHC) at Women's College Hospital in Toronto, Ont, which is a provincial referral centre for patients with illnesses with suspected environmental links, especially MCS, CFS, and FM. PARTICIPANTS: A total of 128 consecutive patients diagnosed with 1 or more of MCS, CFS, or FM, seen between January 2005 and March 2006 at the EHC. MAIN OUTCOME MEASURES: Demographic and socioeconomic characteristics, comorbid diagnoses, duration of illness, health services usage, life stresses, helpful therapeutic strategies, and functional impairment measured by the Short Form-36, compared with Canadian population average values. Factors significantly associated with function in bivariate analyses were included in multiple linear and logistic regression models.
RESULTS: The patient population was predominantly female (86.7%), with a mean age of 44.6 years. Seventy-eight patients had discrete diagnoses of 1 of MCS, CFS, or FM, while the remainder had 2 or 3 overlapping diagnoses. Most (68.8%) had stopped work, and on average this had occurred 3 years after symptom onset. On every Short Form-36 subscale, patients had markedly lower functional scores than population average values, more so when they had 2 or 3 of these diagnoses. Having FM, younger age at onset, and lower socioeconomic status were most consistently associated with poor function.
CONCLUSION: Patients seen at the EHC demonstrated marked functional impairment, consistent with their reported difficulties working and caring for their homes and families during what should be their peak productive years. Early comprehensive assessment, medical management, and social and financial support might avoid the deterioration of function associated with prolonged illness. Education and information resources are required for health care professionals and the public, along with further etiologic and prognostic research.

Entities:  

Mesh:

Year:  2010        PMID: 20154232      PMCID: PMC2821254     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  36 in total

1.  Reproducibility of the University of Toronto self-administered questionnaire used to assess environmental sensitivity.

Authors:  G E McKeown-Eyssen; E R Sokoloff; V Jazmaji; L M Marshall; C J Baines
Journal:  Am J Epidemiol       Date:  2000-06-15       Impact factor: 4.897

2.  Multiple chemical sensitivity: discriminant validity of case definitions.

Authors:  G E McKeown-Eyssen; C J Baines; L M Marshall; V Jazmaji; E R Sokoloff
Journal:  Arch Environ Health       Date:  2001 Sep-Oct

3.  Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms.

Authors:  L A Jason; R R Taylor; C L Kennedy
Journal:  Psychosom Med       Date:  2000 Sep-Oct       Impact factor: 4.312

4.  Is there regional variation in the SF-36 scores of Canadian adults?

Authors:  Wilma M Hopman; Claudie Berger; Lawrence Joseph; Tanveer Towheed; Tassos Anastassiades; Alan Tenenhouse; Suzette Poliquin; Jacques P Brown; Timothy M Murray; Jonathan D Adachi; David A Hanley; Emmanuel A Papadimitropoulos
Journal:  Can J Public Health       Date:  2002 May-Jun

5.  Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.

Authors:  W M Hopman; T Towheed; T Anastassiades; A Tenenhouse; S Poliquin; C Berger; L Joseph; J P Brown; T M Murray; J D Adachi; D A Hanley; E Papadimitropoulos
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

6.  Health-related quality of life in patients with chronic fatigue syndrome: an international study.

Authors:  J Hardt; D Buchwald; D Wilks; M Sharpe; W A Nix; U T Egle
Journal:  J Psychosom Res       Date:  2001-08       Impact factor: 3.006

7.  Symptomatology and etiology of multiple chemical sensitivities in the southeastern United States.

Authors:  Stanley M Caress; Anne C Steinemann; Caitlin Waddick
Journal:  Arch Environ Health       Date:  2002 Sep-Oct

8.  Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome.

Authors:  Savaş Gürsoy; Emin Erdal; Hasan Herken; Ercan Madenci; Belgin Alaşehirli; Nurten Erdal
Journal:  Rheumatol Int       Date:  2002-10-22       Impact factor: 2.631

9.  Chronic fatigue and chronic fatigue syndrome: a co-twin control study of functional status.

Authors:  Richard Herrell; Jack Goldberg; Suzanne Hartman; Megan Belcourt; Karen Schmaling; Dedra Buchwald
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

10.  Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Jonathan R Kerr; Robert Petty; Beverley Burke; John Gough; David Fear; Lindsey I Sinclair; Derek L Mattey; Selwyn C M Richards; Jane Montgomery; Don A Baldwin; Paul Kellam; Tim J Harrison; George E Griffin; Janice Main; Derek Enlander; David J Nutt; Stephen T Holgate
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

View more
  15 in total

1.  Recent insights into 3 underrecognized conditions: Myalgic encephalomyelitis-chronic fatigue syndrome, fibromyalgia, and environmental sensitivities-multiple chemical sensitivity.

Authors:  Howard Hu; Cornelia Baines
Journal:  Can Fam Physician       Date:  2018-06       Impact factor: 3.275

2. 

Authors:  Howard Hu; Cornelia Baines
Journal:  Can Fam Physician       Date:  2018-06       Impact factor: 3.275

3.  Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators.

Authors:  C Rusu; M E Gee; C Lagacé; M Parlor
Journal:  Health Promot Chronic Dis Prev Can       Date:  2015-03       Impact factor: 3.240

4.  Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effects.

Authors:  Iris R Bell; Mary Koithan; Audrey J Brooks
Journal:  Homeopathy       Date:  2013-01       Impact factor: 1.444

5.  Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 6.  Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a Review of Recent Findings.

Authors:  Morris Gerwyn; Michael Maes
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.592

7.  Physicians' perceptions and practices regarding patient reports of multiple chemical sensitivity.

Authors:  Pamela Reed Gibson; Amanda Lindberg
Journal:  ISRN Nurs       Date:  2011-09-07

8.  Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the 'autoimmune (auto-inflammatory) syndrome induced by adjuvants' (ASIA).

Authors:  Nancy Agmon-Levin; Yaron Zafrir; Shaye Kivity; Ari Balofsky; Howard Amital; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 4.505

9.  Allergological and toxicological aspects in a multiple chemical sensitivity cohort.

Authors:  Paolo D Pigatto; Claudio Minoia; Anna Ronchi; Lucia Brambilla; Silvia M Ferrucci; Francesco Spadari; Manuela Passoni; Francesco Somalvico; Gian Paolo Bombeccari; Gianpaolo Guzzi
Journal:  Oxid Med Cell Longev       Date:  2013-12-03       Impact factor: 6.543

10.  Women with multiple chemical sensitivity have increased harm avoidance and reduced 5-HT(1A) receptor binding potential in the anterior cingulate and amygdala.

Authors:  Lena Hillert; Hristina Jovanovic; Fredrik Åhs; Ivanka Savic
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.